LivaNova is a global medical technology company built on decades of experience and a commitment to improve the lives of patients around the world. As a worldwide leader in cardiopulmonary and neuromodulation, LivaNova is dedicated to creating meaningful products and therapies and operating at the topmost level of business ethics and integrity. Corporate responsibility and sustainability are integral to LivaNova. LivaNova has always focused on delivering strong financial results and is committed to doing so in a way that respects the communities and environments in which the Company operates.
LivaNova has established a sustainability strategy delivery program with global coordination to respond to regulatory requirements and commercial needs and generally fall into one of the following focus areas: People, Products, and Planet.
Sustainability
Supporting Well-Being with a Sustainable Business

Driving Sustainability through Effective Governance
Sustainability governance at LivaNova is embedded at multiple levels of the organization, providing an essential foundation for the Company’s priorities. This ensures effective advancement of LivaNova’s sustainability agenda, diligent risk management, and transparent progress reporting. The Corporate Sustainability Team drives the governance structure and is accountable for successful prioritization and execution of the sustainability strategy.
The LivaNova Board of Directors oversees material environmental, social, and governance matters through the Nominating and Corporate Governance Committee (unless specifically delegated to another committee), by way of quarterly updates on sustainability-related activities, including climate-related risks and opportunities. The Executive Leadership Team (ELT) is involved in defining LivaNova’s sustainability vision and strategy, and monitors progress through regular updates and quarterly reviews of sustainability efforts. In addition, the Sustainability Steering Committee (SteerCo), which includes ELT members, meets at least quarterly to support goal setting and business decisions.
The cross-functional ESG Task Force, comprised of leaders throughout the organization, plays a critical role in driving sustainability engagement and managing climate-related risks and opportunities. This group meets biweekly and engages directly with the ELT on the execution of LivaNova's sustainability strategy.
By regularly incorporating feedback from stakeholders and continuing to refine governance practices, LivaNova is committed to creating business value and delivering long-term impact through its sustainability strategy.
Compliance
LivaNova operates within a framework of principles, guidelines, and policies aligned with ethical, social, and environmental responsibilities, and we abide by the highest standards of business ethics and compliance. We are guided by our Code of Ethics and Business Conduct that applies to all employees and board directors of LivaNova and its subsidiaries, and sets the tone for our Global Compliance Program. The LivaNova Third Party Code of Conduct outlines the standards and expectations for ethical and sustainable business conduct of our third parties, as well as their subsidiaries, subcontractors, affiliates, employees, and agents.
At LivaNova, fostering an ethical culture is very important. Raising concerns not only protects our company but also our customers, patients, and each other. LivaNova is committed to its Global Speak Up and Non-Retaliation Policy and maintains an independent, 24/7 Ethics Helpline for reporting any ethical or compliance concerns, without fear of retaliation.
Sustainability Focus Areas

People

Products

Planet

Corporate Content Awards North America 2022
Gold Winner - Best Content Targeted to the CSR Community
Corporate Governance
Our Board of Directors and executive leadership team ensure accountability, transparency and fairness throughout the company. Governance practices influence our corporate strategy, business operations, environmental impacts, ethics & integrity, compensation and management of risk. The Board continually considers corporate governance improvements and models a culture of compliance.